Drugs and Devices

FDA announces plans for review of its opioid policies

On Feb. 4, the Food and Drug Administration (FDA) announced it is planning to assess the agency’s approach to opioid medications, in response to the opioid abuse epidemic. Read more


Related Articles:

Leave a Reply

You have to agree to the comment policy.

 

Shares